Ellevest Inc’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$233K Buy
+873
New +$236K 0.03% 384
2025
Q4
Sell
-754
Closed -$216K 443
2025
Q3
$216K Sell
754
-274
-27% -$73.4K 0.03% 403
2025
Q2
$270K Buy
+1,028
New +$250K 0.04% 323
2023
Q2
Sell
-47
Closed -$9.18K 1054
2023
Q1
$9.18K Sell
47
-274
-85% -$56.4K ﹤0.01% 1049
2022
Q4
$65K Sell
321
-21
-6% -$4.1K 0.01% 544
2022
Q3
$60K Buy
342
+92
+37% +$18.8K 0.01% 534
2022
Q2
$50K Buy
250
+98
+64% +$20.9K ﹤0.01% 566
2022
Q1
$35K Buy
152
+138
+986% +$32.5K ﹤0.01% 617
2021
Q4
$4K Sell
14
-21
-60% -$5.2K ﹤0.01% 1050
2021
Q3
$8K Sell
35
-9
-20% -$2.27K ﹤0.01% 866
2021
Q2
$10K Sell
44
-193
-81% -$44K ﹤0.01% 758
2021
Q1
$52K Buy
237
+19
+9% +$3.81K 0.01% 465
2020
Q4
$38K Buy
218
+22
+11% +$3.8K 0.01% 521
2020
Q3
$32K Sell
196
-94
-32% -$14.9K 0.01% 445
2020
Q2
$41K Buy
290
+36
+14% +$4.98K 0.01% 387
2020
Q1
$28K Buy
254
+84
+49% +$12.1K 0.01% 365
2019
Q4
$25K Buy
170
+167
+5,567% +$24.1K 0.01% 373
2019
Q3
$1K Buy
+3
New +$438 ﹤0.01% 415

Other funds holding LH

Ellevest Inc's LH Position: Q1 2026 in Review

Ellevest Inc opened a new position in Labcorp (LH) in Q1 2026: 873 shares worth $233K. The stake represents 0.03% of the portfolio and ranks #384 among its holdings. This is a return to the name: Ellevest Inc previously reported a position in LH as recently as Q3 2025.

Ellevest Inc first reported a position in LH in Q3 2019 and has held it in 18 quarters since. The position peaked at $270K in Q2 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Ellevest Inc held 873 shares of Labcorp worth $233K as of Q1 2026.
  • Labcorp was a new Ellevest Inc position in Q1 2026.
  • Labcorp made up 0.03% of Ellevest Inc's portfolio in Q1 2026, its #384 holding.
  • Ellevest Inc first reported a position in Labcorp in Q3 2019 and has held it in 18 quarters since.
  • Ellevest Inc's Labcorp position peaked at $270K in Q2 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Ellevest Inc's 13F filing for Q1 2026, filed 11 May 2026.